Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C25H36N2O8 |
| Molecular Weight | 492.5619 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(O)=C(O)C=C1C(=O)OC[C@H](CNC(C)(C)CNC(=O)C2CCOC2)OC(=O)C3(C)CC3
InChI
InChIKey=ANXXSWNMHQHOQC-DJNXLDHESA-N
InChI=1S/C25H36N2O8/c1-15-9-19(28)20(29)10-18(15)22(31)34-13-17(35-23(32)25(4)6-7-25)11-27-24(2,3)14-26-21(30)16-5-8-33-12-16/h9-10,16-17,27-29H,5-8,11-14H2,1-4H3,(H,26,30)/t16?,17-/m0/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5WVS67PLAL
Created by
admin on Sat Dec 16 11:32:08 UTC 2023 , Edited by admin on Sat Dec 16 11:32:08 UTC 2023
|
PRIMARY | |||
|
OT-730
Created by
admin on Sat Dec 16 11:32:08 UTC 2023 , Edited by admin on Sat Dec 16 11:32:08 UTC 2023
|
PRIMARY | The purpose of this study is to evaluate the safety and potential efficacy of a new drug, OT-730 ophthalmic solution (eye drops), in reducing intraocular pressure in the eyes of patients with open angle glaucoma or ocular hypertension. It will be compared with commercial timolol and placebo eye drops. | ||
|
870809-51-1
Created by
admin on Sat Dec 16 11:32:08 UTC 2023 , Edited by admin on Sat Dec 16 11:32:08 UTC 2023
|
PRIMARY | |||
|
11554979
Created by
admin on Sat Dec 16 11:32:08 UTC 2023 , Edited by admin on Sat Dec 16 11:32:08 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
